Dinesh Khanna
Frederick G L Huetwell Professor of Rheumatology and Professor of Internal Medicine
[email protected]

Available to mentor
Dinesh Khanna
Professor
  • Qualifications
  • Center Memberships
  • Recent Publications
    • Qualifications
    • MS
      UCLA, 1237 Murphy Hall x 951419, 2004
    • MB BS
      University College of Medical Sciences, Dilshad Garden, 1996
    Center Memberships
    • Center Member
      Institute for Healthcare Policy and Innovation
    Recent Publications See All Publications
    • Journal Article
      A modified Delphi exercise in physician-perceived risk factors for drug-induced pneumotoxicity in patients with rheumatological disease.
      Cartlidge MK, Brown KK, Chaudhuri N, Corte TJ, Dieudé P, John L, Kelly C, Khanna D, McRorie E, Nicol L, Stewart G, Walsh SLF, Wijsenbeek M, Hirani N, PASSWRD participants . BMC Pulm Med, 2024 Oct 31; 24 (1): 547 DOI:10.1186/s12890-024-03287-0
      PMID: 39482644
    • Journal Article
      Elevated neutrophil extracellular traps in systemic sclerosis-associated vasculopathy and suppression by a synthetic prostacyclin analog.
      Kortam N, Liang W, Shiple C, Huang S, Gedert R, Clair JS, Sarosh C, Foster C, Tsou P-S, Varga J, Knight JS, Khanna D, Ali RA. Arthritis Res Ther, 2024 Jul 25; 26 (1): 139 DOI:10.1186/s13075-024-03379-6
      PMID: 39054558
    • Journal Article
      Systems-based identification of the Hippo pathway for promoting fibrotic mesenchymal differentiation in systemic sclerosis.
      Ma F, Tsou P-S, Gharaee-Kermani M, Plazyo O, Xing X, Kirma J, Wasikowski R, Hile GA, Harms PW, Jiang Y, Xing E, Nakamura M, Ochocki D, Brodie WD, Pillai S, Maverakis E, Pellegrini M, Modlin RL, Varga J, Tsoi LC, Lafyatis R, Kahlenberg JM, Billi AC, Khanna D, Gudjonsson JE. Nat Commun, 2024 Jan 3; 15 (1): 210 DOI:10.1038/s41467-023-44645-6
      PMID: 38172207
    • Journal Article
      Biomarker analysis from the phase 2b randomized placebo-controlled trial of riociguat in early diffuse cutaneous systemic sclerosis.
      Khanna D, Kramer F, Höfler J, Ghadessi M, Sandner P, Allanore Y, Denton CP, Kuwana M, Matucci-Cerinic M, Pope JE, Atsumi T, Bečvář R, Czirják L, De Langhe E, Hachulla E, Ishii T, Ishikawa O, Johnson SR, Riccieri V, Schiopu E, Silver RM, Smith V, Stagnaro C, Steen V, Stevens W, Szücs G, Truchetet M-E, Wosnitza M, Distler O. Rheumatology (Oxford), 2024 Nov 1; 63 (11): 3124 - 3134. DOI:10.1093/rheumatology/keae150
      PMID: 38460548
    • Journal Article
      Development and Initial Validation of the Novel Scleroderma Clinical Trials Consortium Activity Index.
      Ross L, Hansen D, Proudman S, Khanna D, Herrick AL, Stevens W, Baron M, Nikpour M, Australian Scleroderma Interest Group (ASIG), Canadian Scleroderma Research Group (CSRG), the Scleroderma Clinical Trials Consortium Activity Index Working Group . Arthritis Rheumatol, 2024 Nov; 76 (11): 1635 - 1644. DOI:10.1002/art.42939
      PMID: 38937146
    • Journal Article
      A pilot trial of integrating the Patient-Reported Outcome Measurement Information System (PROMIS®) into rheumatology care.
      Gedert R, Ochocki D, Kortam N, Huang S, Nagaraja V, Chakrabarti K, Ford J, Garber M, Lee J, Ognenovski V, Roofeh D, Cella D, Khanna D. Clin Exp Rheumatol, 2024 Oct 25; DOI:10.55563/clinexprheumatol/fp914f
      PMID: 39480493
    • Journal Article
      Inhibiting Triggering Receptor Expressed on Myeloid Cells-1 signaling to ameliorate skin fibrosis.
      Bale S, Verma P, Yalavarthi B, Bajželj M, Hasan SA, Silverman JN, Broderick K, Shah KA, Hamill T, Khanna D, Sigalov AB, Bhattacharyya S, Varga J. JCI Insight, 2024 Oct 17; DOI:10.1172/jci.insight.176319
      PMID: 39418109
    • Journal Article
      Clinically relevant differences between primary Raynaud's phenomenon and secondary to connective tissue disease.
      Di Donato S, Huang S, Pauling JD, Del Galdo F, Sabbagh M, Khanna D, Hughes M. Semin Arthritis Rheum, 2024 Oct; 68: 152521 DOI:10.1016/j.semarthrit.2024.152521
      PMID: 39089171